On October 22, Procter & Gamble saw a Pre-Market Rise of 3.04%, trading at $160.6492/share, with turnover of $1.7948 million.

The move aligns with rising expectations ahead of its quarterly results due the same day. Consensus points to revenue of $22.77 billion, up 2.68% year over year, while adjusted EPS is expected at $1.88 to $1.89, roughly flat to slightly down. A recent analyst note said first-quarter setup looks favorable, citing improving US consumption trends and a lower chance that the prior quarter shipment-consumption mismatch repeats.

Supporting sentiment, several brokerages had recently raised price targets, including to $180, $172, $170, and $166, while maintaining constructive ratings. That said, commentary has also remained cautious on inflation and input-cost pressure, with some expecting management to lean toward the lower half of its full-year EPS range if cost headwinds persist.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)